Universal Ibogaine is a billion dollar co trading company for pennies. Universal Ibogaine Inc. a life science treating addiction has been listed on OTC with ticker symbol $IBOGF has the market capitalization value of $7.611M.
Good things are coming from Universal Ibogaine. It could be a catalyst for the entire space. $IBOGF is the ticker symbol of Universal Ibogaine Inc. listed on OTC. In the last 50 days the moving average of $IBOGF is $0.0507.
Universal Ibogaine Inc. is seen to be doing well in the OTC market with its ticker symbol $IBOGF. The average volume in the last 30 days is recorded to be above $8K.
Margaret Lake Diamond Inc. is an expanding Canadian-holding company with an average volume of 10K+ in the last 3 months. The average volume of the company in the last 10 days is 1K with 12.08M share outstanding. The stock price when the market opened was $0.18.
Margaret Lake Diamond Inc. is a publicly traded diamond exploring company trading in TSX-V with market capitalization of $3.12M.
Margaret Lake Diamonds Inc. is a diamond exploring company listed on TSX-V with ticker symbol, currently sits at $0.18.
$IBO over the years have maintained a solid and supple market cap, currently the company’s market capitalization is valued over $7.57M and is mounting effectively and the shares are actively being traded on OTC at $0.0376 per unit.
Universal Ibogaine Inc. is a Canadian Life science Company trading at OTC with ticker symbol $IBOGF currently sits at $0.0376 with volume around 10K+.
Universal Ibogaine Inc. is an expanding Canadian-holding company with an average volume of $7K in the last 3 months. The average volume of the company in the last 10 days is $5.02K with $190.74M share outstanding. The stock price when the market opened was $0.0397.
"We are happy to have access to Blue Digital's distribution channels, as their range across borders will broaden awareness of our business to new audiences," said Nick Karos, UI's Chief Executive Officer. Because addiction knows no bounds, the remedy we seek must be global in scope." As Blue Digital Media professional radar.
Dr. Sola, a co-founder of Universal Ibogaine and a member of its Board of Directors, has effectively administered over 3,700 ibogaine treatments, more than any other doctor in the world, at an independent clinic in Cancun, Mexico, where he is a partner.
"H.C. Wainwright is a leader in the field and may be a significant strategic partner in our ongoing corporate finance roadmap," said Nick Karos, CEO of Universal Ibogaine. Another crucial step in raising awareness of our brand and service is the chance to share our story with this audience.
"The significance of this occasion cannot be emphasized," said CEO Nick Karos. This is the first gathering of academic researchers, real-world technicians, and government policymakers of its sort. This event will raise awareness of ibogaine's great potential at the highest levels."
Hemostemix Inc. announced that in accordance with its stock option plan, it has granted on February 28, 2022, subject to regulatory approval, a total of 1,494,269 stock options to purchase common shares of Hemostemix to directors, officers, employees and consultants of Hemostemix
Hemostemix Inc. is a publicly traded biotechnology company listed on TSX-V marked with an opening of $0.285.
Hemostemix Inc. is a biotechnology company listed on TSX-V with ticker symbol $HEM has shown growth in its volume. Today the volume is $8.62K.
Universal Ibogaine Inc. holds a significant position over the OTC market with its greater difference between the lower and higher ranges of trading, which is $0.0258-$0.1143 in the last 52 weeks.
Universal Ibogaine Inc. is a life science company listed on OTC with the ticker symbol $IBOGF. In the last 52 weeks the range of the lower and upper price is $0.0258-$0.1143.